| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Acinetobacter baumanniiColistinMoraxellaPseudomonas aeruginosaTigecyclin| 1 | 2006 | Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. | 
| + | - | nl | Crit Care 10(2):R48 (2006) |
| 2 | 2007 | Global challenge of multidrug-resistant Acinetobacter baumannii. |
| + | - | nl | Antimicrob Agents Chemother 51(10):3471-84 (2007) |
| 3 | 2007 | Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. |
| + | - | nl | J Antimicrob Chemother 59(6):1210-5 (2007) |
| 4 | 2006 | Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. |
| + | - | nl | J Antimicrob Chemother 58(5):1078-81 (2006) |
| 5 | 1973 | Moraxella, Acinetobacter, and the Mimeae. |
| + | - | nl | Bacteriol Rev 37(4):522-61 (1973) |
| 6 | 2008 | Acinetobacter baumannii: emergence of a successful pathogen. |
| + | - | nl | Clin Microbiol Rev 21(3):538-82 (2008) |
| 7 | 1996 | Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. |
| + | - | nl | Clin Microbiol Rev 9(2):148-65 (1996) |
| 8 | 2006 | Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. |
| + | - | nl | Clin Microbiol Infect 12(9):826-36 (2006) |
| 9 | 2005 | Clinical impact and pathogenicity of Acinetobacter. |
| + | - | nl | Clin Microbiol Infect 11(11):868-73 (2005) |
| 10 | 2002 | Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. |
| + | - | nl | Clin Microbiol Infect 8(11):687-93 (2002) |
| 11 | 2006 | The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. |
| + | - | nl | J Med Microbiol 55(Pt 12):1619-29 (2006) Falagas ME |
| 12 | 2010 | The pivotal role of long-term care facilities in the epidemiology of Acinetobacter baumannii: another brick in the wall. |
| + | - | nl | Clin Infect Dis 50(12):1617-8 (2010) |
| 13 | 2006 | The epidemiology and control of Acinetobacter baumannii in health care facilities. |
| + | - | nl | Clin Infect Dis 42(5):692-9 (2006) |
| 14 | 2010 | Treatment of Acinetobacter infections. |
| + | - | nl | Clin Infect Dis 51(1):79-84 (2010) |
| 15 | 2008 | Acinetobacter baumannii skin and soft-tissue infection associated with war trauma. |
| + | - | nl | Clin Infect Dis 47(4):444-9 (2008) |
| 16 | 2008 | Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. |
| + | - | nl | Clin Infect Dis 46(8):1254-63 (2008) |
| 17 | 2011 | In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore. |
| + | - | nl | PLoS One 6(4):e18485 (2011) |
| 18 | 2007 | Acinetobacter pneumonia: a review. |
| + | - | nl | MedGenMed 9(3):4 (2007) |
| 19 | 2008 | Why are we afraid of Acinetobacter baumannii? |
| + | - | nl | Expert Rev Anti Infect Ther 6(3):269-71 (2008) |
| 20 | 2008 | Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. |
| + | - | nl | J Antimicrob Chemother 62(1):45-55 (2008) |
